Submitting the first US proposal for an OTC daily oral contraceptive weeks after acquiring the product’s developer and soon after receiving its first approval for an Rx-to-OTC switch wasn’t enough momentum into the second half of the year for Perrigo Company PLC.
Along with its second-quarter results including reported net sales up 14.3% to $1.12bn, the OTC drug and adult and infant...






